Lee D K, Lee A, Wang D P
Department of Pharmacy, Kaoshung Veterans General Hospital, Taipei, Taiwan, Republic of China.
Am J Hosp Pharm. 1991 Jan;48(1):108-10.
The compatibility of cefoperazone sodium and furosemide in 5% dextrose injection stored at two temperatures was studied. Cefoperazone sodium and furosemide were added to 5% dextrose injection to achieve a cefoperazone concentration of 10 mg/mL and a furosemide concentration of 0.2 mg/mL. The admixture was stored in 100-mL vented i.v. containers in the dark under refrigeration (4 degrees C) and at room temperature (25 degrees C); three containers were stored at each temperature. A 1-mL sample was taken from each i.v. container immediately after preparation and after 1, 2, 5, 10, 15, 20, and 25 days to be inspected visually, checked for pH value, and analyzed by a stability-indicating high-performance liquid chromatographic method. No color change or precipitation was observed in any sample at any time during the study. More than 95% of the initial concentrations of both drugs remained for five days at 4 degrees C but for only two days at 25 degrees C. Cefoperazone sodium was somewhat more stable than furosemide under the same storage conditions for 25 days; however, less than a 2% difference between the drugs was noted. Under the conditions of this study, cefoperazone sodium 10 mg/mL and furosemide 0.2 mg/mL in admixtures in 5% dextrose injection are stable for only two days at 25 degrees C and five days at 4 degrees C.
研究了头孢哌酮钠与呋塞米在两种温度下储存于5%葡萄糖注射液中的配伍性。将头孢哌酮钠和呋塞米加入到5%葡萄糖注射液中,使头孢哌酮浓度达到10mg/mL,呋塞米浓度达到0.2mg/mL。混合液储存在100mL带通气孔的静脉输液容器中,分别在冷藏(4℃)和室温(25℃)的黑暗环境下保存;每种温度下储存三个容器。在配制后以及1、2、5、10、15、20和25天后,从每个静脉输液容器中取出1mL样品进行外观检查、pH值检测,并采用稳定性指示高效液相色谱法进行分析。在研究期间的任何时候,任何样品均未观察到颜色变化或沉淀。两种药物的初始浓度在4℃下有超过95%在五天内保持稳定,但在25℃下仅在两天内保持稳定。在相同储存条件下25天,头孢哌酮钠比呋塞米稍稳定一些;然而,两种药物之间的差异不到2%。在本研究条件下,5%葡萄糖注射液中10mg/mL头孢哌酮钠与0.2mg/mL呋塞米的混合液在25℃下仅稳定两天,在4℃下稳定五天。